Clinical Trial

Circulating Tumor DNA Exposure in Peripheral Blood

Study Description

Circulating Tumor DNA Exposure in Peripheral Blood

This is a prospective, multi-center, blinded feasibility study. The objective of this study is to test the feasibility of the detection of tumor DNA of a variety of tumors in peripheral blood using a novel process for the detection of circulating tumor DNA (ctDNA).

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Methods have not been listed for this study. If you require more information about the methods of this study, please inquire with the researcher.

Additional Information

Official Study Title

Circulating Tumor DNA Exposure in Peripheral Blood Using a Novel Process: A Feasibility Study

Clinical Trial ID

NCT03517332

ParticipAid ID

lejxyb